Skip to Content

Prevail Therapeutics Inc

Rating as of

Company Profile

Business Description

Prevail Therapeutics Inc is a gene therapy company leveraging breakthroughs in human genetics with the goal of developing and commercializing disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases. Its pipeline products include PR001, PR006 and PR 004.

430 East 29th Street, Suite 1520
New York, NY, 10016
T +1 917 336-9310
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type
Employees 62